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Abstract
Background
Hypoxic-ischemic encephalopathy (HIE) is one of the most important causes of neonatal
brain injury. Therapeutic hypothermia (TH) is the standard treatment for term newborns
after perinatal hypoxic ischemic injury (HI). Despite this, TH does not provide complete neu-
roprotection. Allopurinol seems to be a good neuroprotector in several animal studies, but it
has never been tested in combination with hypothermia.
Clinical findings show that male infants with (HI) fare more poorly than matched females
in cognitive outcomes. However, there are few studies about neuroprotection taking gender
into account in the results.
The aim of the present study was to evaluate the potential additive neuroprotective effect
of allopurinol when administrated in association with TH in a rodent model of moderate HI.
Gender differences in neuroprotection were also evaluated.
Methods
P10 male and female rat pups were subjected to HI (Vannucci model) and randomized into
five groups: sham intervention (Control), no treatment (HI), hypothermia (HIH), allopurinol
(HIA), and dual therapy (hypothermia and allopurinol) (HIHA). To evaluate a treatment’s
neuroprotective efficiency, 24 hours after the HI event caspase3 activation was measured.
Damaged area and hippocampal volume were also measured 72 hours after the HI event.
Negative geotaxis test was performed to evaluate early neurobehavioral reflexes. Learning
and spatial memory were assessed via Morris Water Maze (MWM) test at 25 days of life.
Results
Damaged area and hippocampal volume were different among treatment groups (p = 0.001).
The largest tissue lesion was observed in the HI group, followed by HIA. There were no
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differences between control, HIH, and HIHA. When learning process was analyzed, no differ-
ences were found. Females from the HIA group had similar results to the HIH and HIHA
groups.
Cleaved caspase 3 expression was increased in both HI and HIA. Despite this, in females
cleaved caspase-3 was only differently increased in the HI group.
All treated animals present an improvement in short-term (Negative geotaxis) and long-
term (WMT) functional tests. Despite this, treated females present better long-term out-
come. In short-term outcome no sex differences were observed.
Conclusions
Our results suggest that dual therapy confers great neuroprotection after an HI event. There
were functional, histological, and molecular improvements in all treated groups. These dif-
ferences were more important in females than in males. No statistically significant differ-
ences were found between HIHA and HIH; both of them present a great improvement. Our
results support the idea of different regulation mechanisms and pathways of cell death,
depending on gender.
Introduction
Hypoxic-ischemic encephalopathy (HIE) is one of the most important causes of neonatal
brain injury. It is associated with high mortality and long-term neurological sequelae [1]. Its
global incidence is around 1–3 per 1000 term births in developed countries [2] with a mortality
rate between 10–15% in those infants with moderate to severe disease. Among the survivors, at
least 36% will present severe neurodevelopmental disabilities and a larger proportion (30%)
will present significant problems including global developmental delay, cognitive problems,
deafness, and epilepsy [3,4].
Therapeutic hypothermia (TH) has been the only proven treatment for term newborns
after perinatal HIE injury [4]. The mechanisms underlying hypothermia neuroprotection are
multifactorial. Suppression of excitotoxicity [5], decreasing oxidative stress [6], and inflamma-
tion [7] modulation of intracellular signaling and programmed cell death [8] seem to be some
of the most important. Although several randomized controlled trials have shown that TH
reduces mortality and improves neurodevelopmental outcome among survivors [9,10,11], this
therapy does not provide complete neuroprotection [12]. Therefore, new therapeutic
approaches to reduce brain injury are necessary. After an HI event, there is a considerable
increase in free radical production, lending support to the idea that oxidative stress plays a key
role in the pathology of secondary brain injury [13]. Taking all the foregoing into account, it
seems reasonable to try to reduce this secondary damage using antioxidant therapies [14,15] in
combination with hypothermia [16].
Some of the most important sources of oxygen free radicals are xanthine oxidase products.
Allopurinol is a xanthine oxidase inhibitor, one of the main prooxidant pathways after HI
that inhibits the conversion of hypoxanthine into xanthine and uric acid, thereby limiting the
toxic overproduction of ROS. It prevents adenosine degradation and oxygen radical forma-
tion, and preserves NMDA receptor integrity, so as a consequence it may reduce brain injury
in HIE through several mechanisms of action which are independent of the proven beneficial
effect of hypothermic treatment in cellular energy metabolism. In high concentrations, it is
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also a direct scavenger of the toxic hydroxyl free radical and a chelator of non-protein-bound
iron [17].
The first reports of the neuroprotective effects of allopurinol in animal models were pub-
lished in the early 1990s [18,19]. Initial histology and molecular data showed promising results
[20,21], and when allopurinol was tested in humans some beneficial effects were demonstrated
on free radical formation, cerebral perfusion, and electrical brain activity, without toxic side
effects [22,23]. Despite this, Benders and colleagues, who only included severely asphyxiated
infants, concluded that no beneficial effects were detected in the short-term clinical evaluation
regardless of its higher safety profile [24,25,26,27]. However, when the long-term neurological
outcome of these patients was evaluated, those with moderate HIE treated with allopurinol
presented better cognition results, suggesting that neonatal allopurinol treatment may improve
long-term results in moderate HIE newborns [25].
Along the same line, a randomized controlled trial focusing on prenatal administration of
the drug (NCT001189007) demonstrated that maternal treatment with allopurinol during fetal
hypoxia did not significantly lower neuronal damage markers in cord blood. Nonetheless, the
post hoc analysis revealed a potential beneficial effect in girls [28].
There is increasing evidence of sex differences in HI outcomes, with males exhibiting more
severe neurological deficits relative to matched females [29]. In vitro, it has been demonstrated
that mechanisms of cell death and brain lesion have different sex injury pathways [30, 31].
Taking all this into account, it is reasonable to make examine sex-specific treatment effects.
The aim of the present study was to evaluate the effects of combining hypothermia and allo-
purinol in an animal model of HI brain injury. Sex differences in neuroprotection were also
evaluated.
Material and methods
Procedures
This study was carried out in strict accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was
approved by the Ethics Committee for Animal Experimentation of the University of Barcelona
(Permit Number: 6575), following European (2010/63/UE) and Spanish (RD 53/2013) regula-
tions for the care and use of laboratory animals. All surgery was performed under inhaled iso-
fluorane, and all efforts were made to minimize the animals’ suffering and the number of them
used to carry out the experiments.
Animals and ethics statement
Postnatal day 10 (P10) Wistar rats (HARLAM, Netherlands) were used in this study. After
birth, animals were kept with their mothers in cages with 12-hour light/dark cycles at a con-
stant temperature of 22 ± 1˚C with free access to food and water. All surgical and experimental
procedures were in accordance with the international recommendations of the Guide for the
Care and Use of Laboratory animals. Experimental procedures were approved by the local eth-
ical committee of the University of Barcelona (Permit Number: 6575), following European
(2010/63/UE) and Spanish (RD 53/2013) regulations for the care and use of laboratory ani-
mals. All surgery was performed under inhaled isofluorane, and all efforts were made to mini-
mize the animals’ suffering and the number of them used.
Animals were euthanized prior to the end of the experiments by the administration of intra-
peritoneal thiopental after being anesthetized with inhaled isofluorane (2%).
Hypoxia-ischemia animal model. P10 pups were randomized into 5 experimental
groups. Neonatal Hypoxia Ischemia (HI) was induced using the Rice-Vannucci model. Briefly,
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unilateral ligation of the left common carotid artery was performed and afterwards animals
were exposed to 90 minutes of hypoxia (8% oxygen atmosphere), as previously described [26].
At the end of the HI, pups were treated with systemic hypothermia (32.5–33˚C) or normo-
thermia (36–36.5˚C) in temperature-controlled chambers for 5 hours. Temperature was conti-
nuosly measured in one pup in each chamber with a rectal temperature probe (IT-21;
Physitemp Instruments).
Sham-operated animals were anesthethized and a skin incision was performed to expose
the left common carotid artery but without artery ligation or hypoxia.
All treatment groups received a single intraperitoneal injection of allopurinol (Zylosprim
sodium, Burroughs Wellcome, Research Triangle Park, NC) at 135 mg/kg (volume: 0.01 ml/g)
or saline, 15 min after hypoxia, depending on the randomization, before beginning hypothermia
or normothermia protocol. Allopurinol doses were the same as that used by Palmer et al [19].
Animal randomization and experimental design. Five experimental groups were estab-
lished for global evaluation.
Animals were randomized in: Sham-treated (control), HI+normothermia (HI), HI+
allopurinol (HIA), HI+hypothermia (HIH), and HI+hypothermia+ allopurinol (HIHA).
A diagram of the experimental design including the number of animals used for each con-
dition and analysis is presented in Fig 1.
Histological evaluation: Measurement of infarct and hippocampal
volume
Pups were deeply anesthetized with isofluorane and perfused transcardically with 4% parafor-
maldehyde 72 hours after the HI injury. Brains were carefully removed and maintained for 12
hours in the same solution at 4˚C, and then cryoprotected in 30% Sucrose/PBS at 4˚C for 24-
48h, and stored at -80˚C. Forty μm coronal sections were made and stained with hematoxylin-
eosin. The midline of each brain section was identified on the image and the brain divided by
hemispheres (left vs right). Two sections from each block representing cortex, hippocampus,
basal ganglia, and thalamus were scanned at 1200 dpi resolution. ImageJ (ImageJ, National
Institutes of Health, USA; www.NIH.gov) was used to measure the area of viable tissue in the
left and right hemispheres. The ratio of the measured brain area was calculated for the two sec-
tions per brain and the average percentage of area loss was calculated (1–(Area Ratio (right vs
left)) [16]
Hippocampal volume was analysed comparing the affected hippocampal side with the con-
tralateral hippocampus.
Neuropathological score. Thorensen neuropathological score was used for the cerebral
cortex and hippocampus. The evaluation was performed at the same time as the histologial
evaluation. In the cerebral cortex, scoring was performed as follows: 0: no histological damage;
1:< 10% affected area; small, patchy or incomplete infarcts; 2: 20–30% affected area; partly
confluent infarcts; 3: 40–60% affected area, with large confluent infarcts; 4:> 75% affected
area; total disaggregation of the tissue.
Findings were: in the hippocampus 1:<20% affected area, necrotic neurons only in the
most lateral areas; 2: 50% affected area, patchy areas in all sectors; 3: 75% affected area, with
more extensive areas of necrotic neurons; 4: 100% affected, complete infarction of hippocam-
pus including gyrus dentatus [27].
Western blot
Pups were sacrificed by decapitation 24 hours after the HI injury and their brains were rapidly
removed and weighed. Protein extracts from the right hippocampus were separated by
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SDS-PAGE and electro-transferred into a nitrocellulose membrane. Membranes were blocked
with 5% nonfat dry milk in Tris-buffered saline and incubated first with primary antibodies
against cleaved caspase-3 ((Asp175) (5A1E) Rabbit #Cell signaling, 1/500) or GAPDH
(D16H11) XP Rabbit #Cell signaling, 1/20000) overnight at 4˚C, and then with their corre-
sponding HRP-conjugated secondary antibody (PROMEGA anti-Rabbit 1/5000). Protein sig-
nal was detected using the ECL chemiluminescent system (Amersham, Buckinghamshire,
UK).
Negative geotaxis
On P15, 5 days after the HI insult, the animals underwent the ‘negative geotaxis’ test, which
examines the time taken to rotate 180˚ from a head-down to a head-up position when placed
head down on a 45˚ slope [32]. This is an innate postural response that appears in the second
week of life in normal pups.
Fig 1. Study diagram. P10: 10 days of life, LCA: Left common carotid, ST: Sham-treated; HI: Hypoxic-ischemic, HIA: Hypoxic-ischemic allopurinol, HIH:
Hypoxic-ischemic hypothermia, HIHA: Hypoxic-ischemic hypothermia allopurinol, HE: Histological evaluation, MWMT: Water maze test.
https://doi.org/10.1371/journal.pone.0184643.g001
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Functional evaluation: Water maze test
Spatial memory evaluation was carried out in a version of Morris’s water maze pool (MWM)
[33] modified for small animals (63 cm l, 43 cm wide, and 35 cm high), with the water temper-
ature set at 22–23˚C and water made opaque by latex suspension (Fig 1). The escape latency
(EL), defined as the time taken to reach the platform, was measured during each trial as an
indicator of learning. At P25, all pups from each experimental group were trained four times
per day, for 10 consecutive days.
Statistical analysis
Each litter was randomized to include pups of each sex and treatment group. For histological
analysis, western blot and negative geotaxis test, a minimum of n = 4 per sex to observe a 50%
difference by Wilcoxon signed rank test (80% power, a = 0.05) was required. This figure was
based on previous studies with antioxidant treatments [34]. For WMT, at least 6 animals per
sex and per condition were necessary, as reported in other studies.
The anthropometric results were expressed as mean and range. Infarct and hippocampal
volume were expressed as mean ± SEM. Statistical differences were analyzed using one-way
ANOVA followed by Turkey multiple comparison procedure. For western blot, the values
were expressed as a ratio of GAPDH and then converted to percentage of control group (pre-
sented as bar diagrams) and represented as mean ± SEM. Due to problems with ascertainment
of normal distribution in small sample sizes, data were also analyzed with non-parametric tests
(Kruskal-Wallis test) which yielded identical results and statistical significance. Negative geo-
taxis test was analysed using a Kruskall-wallis test. The escape latency of rats in the MWM
training was analysed using two-way ANOVA (time, group) with repeated measures, corrected
with Bonferroni adjustments. A criterion of p<0.05 was considered significant. All analyses
were performed using Stata 13.
Results
Survival rates, weights, and cephalization index
A total of 260 animals were used during the whole experiment. Twenty-two animals (9.7%)
died after the procedure, before being randomized. After the treatment, there were 4 casualties
in the HI and 2 in the HIA. None of the animals treated with HIH or HIHA died. There was a
significant difference in weight evolution between treated animals and those in the HI group,
which were smaller (P = 0.004).
Histopathological analysis
Histological evaluation was performed 72 hours after the HI event, in coronal sections stained
with hematoxylin-eosin. The mean area loss in the untreated group was 33.60% (±3.30). The
mean area losses in the different treatment groups were: HIA 13.41% (±3.37); HIH, 5.1%
(±1.04); HIHA, 3.8% (±0.99). Mean area loss in the control group was 0.37% (±0.5). Infarct
area was reduced in treated animals (HIA HIH, HIHA) with respect to the HI untreated group
(p<0.0001) (Fig 2A). No statistically significant differences were found between HIH and
HIHA (Fig 2A).
When whole infarct area was analysed by sex, there were no statistically significant differ-
ences between males and females (p = 0.321). But when it was analyzed by sex and condition,
HIA females exhibited a smaller infarct volume than HI females (p = 0.037). Moreover, there
were no differences in infarct volume among females from the HIA, HIH, and HIHA groups
Hypothermia and allopurinol in a hypoxic-ischemic animal model
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(p = 0.151; p = 1; p = 1) (Fig 2A). In males, infarct area was reduced in HIH and HIHA, but no
stadistically significant differences were found between HIA and HI (Fig 2A).
There were also differences in hippocampal volume between treatment groups (p<0.0001).
HI animals without treatment presented a smaller hippocampus when compared to the others
while there were no differences between the HIH, HIHA, and control groups (p = 1) (Fig 2B).
When sex was considered, there were no differences in the hippocampal volume between
HIA, HIH, and HIHA in females (p = 0.398; p = 1; p = 1). Meanwhile in males, the hippocam-
pal volume of those animals treated with allopurinol was similar to the HI ones, and different
from the others (p = 0.003) (Fig 2B).
Neuropathological score
Neuropathological score was different in the groups (p = 0.001). In the post-hoc analysis, con-
trol (p = 0.001), HIH (p = 0.001), and HIHA (p = 0.001) were different from HI and HIA.
Fig 2. Histological evaluation. A: Graphical representation of the percentage of brain area lost in the affected hemisphere with
respect to the contralateral hemisphere by experimental group (global), and by group and gender (Male, Female) B: Graphical
representation of the hippocampal volume in the affected hemisphere by experimental group (global), and by group and gender
(male, female) ST: Sham-treated; HI: Hypoxic-ischemic, HIA: Hypoxic-ischemic allopurinol, HIH: Hypoxic-ischemic hypothermia,
HIHA: Hypoxic-ischemic hypothermia allopurinol. Volume areas are expressed in arbitrary units. * Significant differences p<0.05.
https://doi.org/10.1371/journal.pone.0184643.g002
Hypothermia and allopurinol in a hypoxic-ischemic animal model
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Histological structure was better preserved in control and hypothermia-treated animals (HIH
and HIHA) than in HI and HIA, in which histological damage was more evident, with large
infarcts and affected areas.
When gender was taken into account, there were also differences in males between groups
(p = 0.0004); control (p = 0.001), HIH (p = 0.0004), and HIHA (p = 0.0006) were different
from HI and HIA. In females, there were also differences among all the groups (p = 0.003), but
control (p = 0.02) HIH (p = 0.036), HIHA (p = 0.036), and HIA (p = 0.029) were different
from HI (Fig 3).
No differences were detected between HIH and HIHA groups (p = 0.8039).
Cleaved caspase-3 activation
To determine whether the observed sex- and treatment-dependent reduction in the infarcted
area was due to early protection against apoptosis, the level of cleaved caspase-3, an indicator
of apoptosis, was evaluated with western blot (Fig 4). At 24h post-HI, males showed increased
levels of cleaved caspase-3 in the HI and HIA groups compared to controls (p = 0.0032). Mean-
while cleaved caspase-3 levels remained at control levels in the other treatment groups (HIH
and HIHA). In contrast, in females, cleaved caspase-3 was only differently increased in the HI
group (p = 0.0117) while it remained at control levels in the HIA, HIH, and HIHA groups,
which showed reduced cleaved caspase-3 levels when compared to the HI group (HIHA
p = 0.0249, HIA p = 0.046, HIH p = 0.025). No differences were detected between the HIH and
HIHA groups (p = 0.4982).
Fig 3. Macroscopic-microscopic histologic evaluation. A: Neuropathological brain scores. B:
Representative photograph of perinatal coronal brain sections of the different experimental groups. ST:
Sham-treated; HI: Hypoxic-ischemic, HIA: Hypoxic-ischemic allopurinol, HIH: Hypoxic-ischemic hypothermia,
HIHA: Hypoxic-ischemic hypothermia allopurinol.
https://doi.org/10.1371/journal.pone.0184643.g003
Hypothermia and allopurinol in a hypoxic-ischemic animal model
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Negative geotaxis test evaluation
Negative geotaxis test was different between groups (p = 0.002). All treatment groups pre-
sented better results than non-treated animals. When gender was taken into account these dif-
ferences were also the same. (See supporting information)
Water maze test evaluation
The Morris water maze test was used to evaluate the effects of the different treatments on
learning and spatial memory. For each animal, escape latency (EL) was recorded 4 times a day
for ten consecutive days, and the results were analyzed with two-way ANOVA. A graphical
representation of learning performance by group and sex is shown in Fig 5. All groups
acquired the task and improved their performance over time (p<0.0001), but with significant
differences in the learning process, with the HI group being the worst.
Post hoc analysis revealed no differences in learning process among the control, HIH
(p = 0.181), and HIHA (p = 0.709) groups, which were better than HI (p = 0.001) and HIA
(p = 0.002).
Gender was also analysed as a possible confounding learning factor, but no differences were
found in learning process between males and females (p = 0.965).
Learning progression was then analysed by gender and condition. In males, global learning
was different between treatment groups (p = 0.001), but there were no differences between
control, HIH (p = 0.18), and HIHA (p = 0.502). Meanwhile for HIA and HI the learning pro-
cess was significantly worse than for the other groups (HIH, HIHA, and controls) (p = 0.0001)
(p = 0.008).
In females, global learning was also different between groups (p = 0.001). When learning
process was analysed by treatment only the HI group showed significantly poorer scores
(p = 0.001), while control, HIH (p = 0.999), HIHA (p = 0.991), and HIA (p = 0.719) showed
normal learning performance.
In summary, HIHA is a good neuroprotective strategy, although in males it does not add
many benefits to HIH. Our results indicate that in females, HIA and HIHA increase
Fig 4. Cleaved caspase-3 expression. Western blot and densitometry analysis of cleaved caspase-3
protein in the hippocampal tissue of males and females from the different experimental groups. GAPDH was
used as protein loading control. Abbreviatons: Control; HI: Hypoxic-ischemic, HIA: Hypoxic-ischemic
allopurinol, HIH: Hypoxic-ischemic hypothermia, HIHA: Hypoxic-ischemic hypothermia allopurinol. *
Significant differences p<0.05.
https://doi.org/10.1371/journal.pone.0184643.g004
Hypothermia and allopurinol in a hypoxic-ischemic animal model
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neuroprotection, reducing infarct volume and preserving hippocampus. Moreover, their neu-
roprotective effect was long lasting, as learning outcomes were significantly improved at
adolescence.
Discussion
In the present study, we assessed the effect of dual therapy hypothermia + allopurinol (HIHA)
after moderate focal HI in P10 rats. We found signs of reduced apoptosis and a global
improvement in the neuropathological score and functional outcome in all treatment groups
(HIA, HIH, and HIHA). Moreover, a sex-specific benefit of allopurinol treatment was
detected. Females from the allopurinol-treated groups showed decreased markers of apoptosis
and better water maze performance than males with the same treatment (HIA, HIHA).
Fig 5. Water maze test. Plot representing the average escape latency in four trials performed each day.
Results were expressed as mean of escape latency. Abbreviatons: ST: Sham-treated; HI: Hypoxic-ischemic,
HIA: Hypoxic-ischemic allopurinol, HIH: Hypoxic-ischemic hypothermia, HIHA: Hypoxic-ischemic
hypothermia allopurinol.
https://doi.org/10.1371/journal.pone.0184643.g005
Hypothermia and allopurinol in a hypoxic-ischemic animal model
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TH intervenes in many pathways after HI injury, reducing metabolic rate and glutamate
release, decreasing oxygen species, and regulating expression of inflammatory and apoptic cas-
cades [35]. Despite the implementation of TH as a standard of care in many clinical units for
HIE [12], it does not provide complete neuroprotection [36], making further investigation
into additional therapies to improve neurological outcomes necessary. Xenon [16], Epo
[37,38], N-Acetylcysteine (NAC) [34], and cannabidiol [39] are some of the drugs that have
been tested in experimental models to potentiate the effects of TH. Historically, one of the first
strategies evaluated for HIE treatment was allopurinol, an antioxidant molecule reported to act
as a mild neuroprotective agent [40].
Oxidative stress is involved in HI injury physiopathology [41]. The neonatal brain handles
oxidative stress poorly, with antioxidant activity less than half of adult levels [42,43]. One of
the most important pro-oxidant pathways of free radical production is xanthine oxidase (XO)
[44]. XO enzyme plays a key role in the high-energy phosphate system [45]. In physiological
conditions, it coexists with xanthine dehydrogenase (XDH). Many investigators agree that
XDH activity is converted by sulfhydryl oxidation or limited proteolysis to an oxidase that pro-
duces superoxide and hydrogen peroxide. It is worth noting, nevertheless, that both XO and
XDH can oxidize NADH, with concomitant formation of reactive oxygen species [46,47].
Physiologically, XO and XDH participate in a variety of biochemical reactions including the
hydroxylation of various purines, pterins, and aromatic heterocycles, thereby contributing to
the detoxification or activation of endogenous compounds and xenobiotics. One of XOR’s pri-
mary roles is the conversion of hypoxanthine to xanthine and xanthine to uric acid. Allopuri-
nol, a xanthine oxidase inhibitor, acts by interrupting the conversion of hypoxanthine into
xanthine and uric acid, limiting the production of toxic reactive oxygen species [19,27]. In
addition, allopurinol is a chelator of non-bound protein iron (NBPI) and a direct scavenger of
hydroxyl free radicals [48]. All these properties suggest it should be useful as a neuroprotective
agent. Palmer and collegues demonstrated its neuroprotective effects in P7 rats after HI [19].
When it was tested in humans, short-term outcome improvement could not be confirmed
[49]. Apparently, no advantage from neonatal treatment was seen when the interval of treat-
ment initiation was very long. Despite this, some years later, when long-term outcome was
evaluated (at 4–8 years) in those babies [49], moderately asphyxiated infants treated with allo-
purinol presented a reduction in the risk of death or severe disability [25].
As has been pointed out in many studies, the major drawback to postasphyxial hypothermia
or pharmacological treatment is the small therapeutic window in which treatment must be ini-
tiated. This is even truer if the aim is to avoid or reduce free radical stress. The optimal point
in time to start antioxidative treatment is at birth or even before birth. Trying to simulate this
condition, many authors have suggested that antenatal administration, during labor, could
amplify its effects. Torrance and colleagues reported a decrease in p-100B in plasma leves in
those fetuses that had received antenatal allopurinol when an HI situation was suspected [50].
Some years later, a randomised controlled trial suggested that allopurinol had a potential neu-
roprotective effect in girls as indicated by lower S100β and neuroketal values in the treatment
group [51].
Our study reveals that the combination of hypothermia + allopurinol after moderate focal
HI in P10 rats decreases infarct and improves residual brain volumes at 72 h, although in
males it does not provide more neuroprotection than hypothermia alone. Infarct volume at 72
h was reduced from 33.60% in the untreated group to 13.41% in HIA, 5.1% in HIH, and 3.8%
in HIHA. These results are in accordance with the first reports on hypothermia in which the
infarct area was reduced to about 50% when compared with the vehicle [52]. In those initial
papers, no sex differences were reported.
Hypothermia and allopurinol in a hypoxic-ischemic animal model
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In the same line, in our study, the hippocampal volume was better preserved in HIA, HIH,
and HIHA females than in HI. Interestingly, allopurinol administration seemed to increase the
neuroprotective effect in females, not only in those that received combined therapy (HIHA),
but also in those females that received it without TH (HIA) when compared to HI. It is impor-
tant to point out that in our study allopurnol administration was very early, less than 15 min-
utes after the HI injury, in order to avoid radical production, thereby simulating the situation
that seems to happen when it is administered during labor ([51]. These results are also in
accordance with what Nie and colleages reported with another antioxidant therapy, N-acetyl-
cysteine (NAC), suggesting that antioxidants may provide less neuroprotection in males [38].
Sex differences have been reported in neonatal models of hypoxic-ischaemic brain injury [53].
Additionally, in humans, male infants are more vulnerable to perinatal insult, suffering worse
long-term cognitive deficits compared to females with equivalent injury [54,55,56]. Recent
studies have demonstrated that mechanisms of cell death vary depending on sex [57,58].
After an HI event, morphological features of three different cell death types can be
observed: necrotic, apoptotic, and autophagic cell death [59,60]. The best known cell death
forms are necrosis and apoptosis, even though the importance of auhophagy-mediated cell
death has recently become a field of interest [61,62]. Apoptosis has been well described as a
programmed delayed cell death mechanism with different intracellular signaling pathways.
Complete understanding of this process represents a potential target for neuroprotective
interventions.
Although there are multiple pathways to programmed cell death, caspase-3 is the final ‘exe-
cutioner,’ and thus caspase-3 activation may be used as a reasonable marker of apoptosis. It
has been demonstrated that hypothermia reduces caspase-3 expression in newborn rats [63].
In our animals, caspase-3 was increased in HI animals 24h post-injury when compared to the
other groups, as has previously been demonstrated [64]. Supporting histological results, there
was also a decrease in caspase-3 activity in females that received allopurinol (HIHA, HIA).
Oxidant reagents can lead to the activation of caspases, triggering apoptosis [65]. Our results
suggest that allopurinol administration alone or in combination with hypothermia may reduce
free radical liberation, decreasing caspase activation and consequently reducing brain injury.
This process, as explained above, seems to be more pronounced in females. This is in accor-
dance with a recently published hypothesis suggesting that programmed cell death in females
depends mainly on caspase activation [30], as well as on their greater sensitivity to redox
status.
Regarding functional performance, we found the same tendency in histological, molecular,
and learning and memory tests. Treated animals (HIA, HIH, HIHA) had better results in
WMT. When this was analysed taking gender into account, female allopurinol-treated (alone
or in combination with hypothermia) animals achieved better results than males, again. The
functional recovery was almost complete.
Despite these data, we found no consistent results to support the idea that hypothermia
+ allopurinol was better than hypothermia alone. Nevertheless, it is important to point out that
the effect of both treatments independently was very significant, and therefore it is quite diffi-
cult to gain even more neuroprotection, especially with so few animals.
Dual therapy has a good neuroprotection spectrum. Other outcomes and molecular issues
should be evaluated to test their potential benefits when compared to hypothermia alone.
Conclusions
There is increasing evidence that neuroprotective strategies may have different effects depend-
ing on sex [29]. Our results also support this notion and, together with other published data,
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invite the reasonable conclusion that gender plays an important role in the effectiveness of
each therapy. Those therapies that act by inhibiting the caspase-dependent pathway would
have better results in females, and even more so if they were antioxidant therapies. Therefore,
it seems reasonable that to achieve better neuroprotection, several therapeutic strategies should
be used, and many individual considerations such as gender should be taken into account to
indicate the best therapy for each patient.
Supporting information
S1 Fig. Negative geotaxis test results. All treated groups presented better results than the HI
ones. No differences in sex were detected.
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